Streptococcus pneumoniae colonisation: The key to pneumococcal disease

Lancet Infectious Diseases

Volumn 4, Issue 3, 2004, Pages 144-154

  Bogaert, D ^b   De Groot, R ^b   Hermans, P W M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b Erasmus MC Sophia Rotterdam ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN G; STREPTOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL MENINGITIS; BACTERIAL STRAIN; DRUG CONJUGATION; HUMAN; NASOPHARYNX; PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEPSIS; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ADOLESCENT; ADULT; BACTERIAL ADHESION; CARRIER STATE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NASOPHARYNX; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 1442299471     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(04)00938-7     Document Type: Review

References (148)

1. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997; 46: 1-24.
2. Obaro S., Adegbola R. The pneumococcus: carriage, disease and conjugate vaccines. J Med Microbiol. 51:2002;98-104.
3. Koedel U., Scheld W.M., Pfister H.W. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis. 2:2002;721-736.
4. Paton J.C., Andrew P.W., Boulnois G.J., Mitchell T.J. Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins. Annu Rev Microbiol. 47:1993;89-115.
5. Bruyn G.A., Zegers B.J., van Furth R. Mechanisms of host defense against infection with Streptococcus pneumoniae. Clin Infect Dis. 14:1992;251-262.
6. Gray B.M., Converse GM 3rd, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis. 142:1980;923-933.
7. Faden H., Duffy L., Wasielewski R., Wolf J., Krystofik D., Tung Y. Relationship between nasopharyngeal colonization and the development of otitis media in children. J Infect Dis. 175:1997;1440-1445.
8. Hoge C.W., Reichler M.R., Dominguez E.A., et al. An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med. 331:1994;643-648.
9. Kristinsson K.G. Epidemiology of penicillin resistant pneumococci in Iceland. Microb Drug Resist. 1:1995;121-125.
10. Munoz R., Coffey T.J., Daniels M., et al. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J Infect Dis. 164:1991;302-306.
11. Principi N., Marchisio P., Schito G.C., Mannelli S. Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Ascanius Project Collaborative Group. Pediatr Infect Dis J. 18:1999;517-523.
12. de Galan B.E., van Tilburg P.M., Sluijter M., et al. Hospital-related outbreak of infection with multidrug-resistant Streptococcus pneumoniae in The Netherlands. J Hosp Infect. 42:1999;185-192.
13. Mandigers C.M., Diepersloot R.J., Dessens M., Mol S.J., van Klingeren B. A hospital outbreak of penicillin-resistant pneumococci in The Netherlands. Eur Respir J. 7:1994;1635-1639.
14. Millar M.R., Brown N.M., Tobin G.W., Murphy P.J., Windsor A.C., Speller D.C. Outbreak of infection with penicillin-resistant Streptococcus pneumoniae in a hospital for the elderly. J Hosp Infect. 27:1994;99-104.
15. Reichler M.R., Rakovsky J., Slacikova M., et al. Spread of multidrug-resistant Streptococcus pneumoniae among hospitalized children in Slovakia. J Infect Dis. 173:1996;374-379.
16. Shi Z.Y., Enright M.C., Wilkinson P., Griffiths D., Spratt B.G. Identification of three major clones of multiply antibiotic-resistant Streptococcus pneumoniae in Taiwanese hospitals by multilocus sequence typing. J Clin Microbiol. 36:1998;3514-3519.
17. Leiberman A., Dagan R., Leibovitz E., Yagupsky P., Fliss D.M. The bacteriology of the nasopharynx in childhood. Int J Pediatr Otorhinolaryngol. 49:(suppl 1):1999;S151-S153.
18. Faden H., Duffy L., Williams A., Krystofik D.A., Wolf J. Epidemiology of nasopharyngeal colonization with nontypeable Haemophilus influenzae in the first two years of life. Acta Otolaryngol Suppl. 523:1996;128-129.
19. Kyaw M.H., Christie P., Jones I.G., Campbell H. The changing epidemiology of bacterial meningitis and invasive non-meningitic bacterial disease in scotland during the period 1983-99. Scand J Infect Dis. 34:2002;289-298.
20. Nouwen J.L., van Belkum A., Verbrugh H.A. Determinants of Staphylococcus aureus nasal carriage. Neth J Med. 59:2001;126-133.
21. Givon-Lavi N., Fraser D., Porat N., Dagan R. Spread of Streptococcus pneumoniae and antibiotic-resistant S. pneumoniae from day-care center attendees to their younger siblings. J Infect Dis. 186:2002;1608-1614.
22. Faden H., Stanievich J., Brodsky L., Bernstein J., Ogra P.L. Changes in nasopharyngeal flora during otitis media of childhood. Pediatr Infect Dis J. 9:1990;623-666.
23. Bogaert D., Engelen M.N., Timmers-Reker A.J., et al. Pneumococcal carriage in children in The Netherlands: a molecular epidemiological study. J Clin Microbiol. 39:2001;3316-3320.
24. El Ahmer O.R., Essery S.D., Saadi A.T., et al. The effect of cigarette smoke on adherence of respiratory pathogens to buccal epithelial cells. FEMS Immunol Med Microbiol. 23:1999;27-36.
25. Bakir M., Yagci A., Ulger N., Akbenlioglu C., Ilki A., Soyletir G. Asymtomatic carriage of Neisseria meningitidis and Neisseria lactamica in relation to Streptococcus pneumoniae and Haemophilus influenzae colonization in healthy children: apropos of 1400 children sampled. Eur J Epidemiol. 17:2001;1015-1018.
26. Kluytmans J., van Belkum A., Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 10:1997;505-520.
27. Garcia-Rodriguez JA, Fresnadillo Martinez MJ. Dynamics of nasopharyngeal colonization by potential respiratory pathogens. J Antimicrob Chemother 2002; 50 (suppl C): 59-74.
28. Ghaffar F., Friedland IR Jr., McCracken G.H. Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae. Pediatr Infect Dis J. 18:1999;638-646.
29. Harabuchi Y., Faden H., Yamanaka N., Duffy L., Wolf J., Krystofik D. Nasopharyngeal colonization with nontypeable Haemophilus influenzae and recurrent otitis media. J Infect Dis. 170:1994;862-866.
30. Simell B., Korkeila M., Pursiainen H., Kilpi T.M., Kayhty H. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children. J Infect Dis. 183:2001;887-896.
31. Simell B., Kilpi T.M., Kayhty H. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children. J Infect Dis. 186:2002;1106-1114.
32. Uehara Y., Kikuchi K., Nakamura T., et al. Inhibition of methicillin-resistant Staphylococcus aureus colonization of oral cavities in newborns by viridans group streptococci. Clin Infect Dis. 32:2001;1399-13407.
33. Tano K., Grahn-Hakansson E., Holm S.E., Hellstrom S. Inhibition of OM pathogens by alpha-hemolytic streptococci from healthy children, children with SOM and children with rAOM. Int J Pediatr Otorhinolaryngol. 56:2000;185-190.
34. Ghaffar F., Muniz L.S., Katz K., et al. Effects of large dosages of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media. Clin Infect Dis. 34:2002;1301-1309.
35. Pericone C.D., Overweg K., Hermans P.W., Weiser J.N. Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract. Infect Immun. 68:2000;3990-3997.
36. Mc Leod J.W., Gordon J. Production of hydrogen peroxide by bacteria. Biochem J. 16:1922;499-506.
37. Dahiya R.S., Speck M.L. Hydrogen peroxide formation by lactobacilli and its effect on Staphylococcus aureus. J Dairy Sci. 51:1968;1068-1072.
38. Bogaert D, Koppen S, Boelens H, et al. Epidemiology and determinants of nasopharyngeal carriage of bacterial pathogens in healthy Dutch children. Program and abstracts of the 21st Annual Meeting of the European Society for Paediatric Infectious Diseases; Giardini Naxos; April 9-11, 2003.
39. Regev-Yochay G, Dagan R, Raz M, et al. Is nasopharyngeal carriage of Streptococcus pneumoniae protective against carriage of Staphylococcus aureus? 43rd ICAAC; Chicago; Sept 14-17, 2003. Abstr G-2048.
40. Lipsitch M., Dykes J.K., Johnson S.E., et al. Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model. Vaccine. 18:2000;2895-2901.
41. Watson D.A., Musher D.M. A brief history of the pneumococcus in biomedical research. Semin Respir Infect. 14:1999;198-208.
42. Magee A.D., Yother J. Requirement for capsule in colonization by Streptococcus pneumoniae. Infect Immun. 69:2001;3755-3761.
43. Bruyn G.A., van Furth R. Pneumococcal polysaccharide vaccines: indications, efficacy and recommendations. Eur J Clin Microbiol Infect Dis. 10:1991;897-910.
44. Swiatlo E., Champlin F.R., Holman S.C., Wilson W.W., Watt J.M. Contribution of choline-binding proteins to cell surface properties of Streptococcus pneumoniae. Infect Immun. 70:2002;412-415.
45. Tuomanen E.I. The biology of pneumococcal infection. Pediatr Res. 42:1997;253-258.
46. Cundell D.R., Gerard N.P., Gerard C., Idanpaan-Heikkila I., Tuomanen E.I. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature. 377:1995;435-438.
47. McCullers J.A., Rehg J.E. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis. 186:2002;341-350.
48. Rosenow C., Ryan P., Weiser J.N., et al. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol Microbiol. 25:1997;819-829.
49. Balachandran P., Brooks-Walter A., Virolainen-Julkunen A., Hollingshead S.K., Briles D.E. Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect Immun. 70:2002;2526-2534.
50. Tuomanen E.I. Pathogenesis of pneumococcal inflammation: otitis media. Vaccine. 19:(suppl 1):2000;S38-S40.
51. Ring A., Weiser J.N., Tuomanen E.I. Pneumococcal trafficking across the blood-brain barrier: molecular analysis of a novel bidirectional pathway. J Clin Invest. 102:1998;347-360.
52. Weiser J.N., Bae D., Fasching C., Scamurra R.W., Ratner A.J., Janoff E.N. Antibody-enhanced pneumococcal adherence requires IgA1 protease. Proc Natl Acad Sci USA. 100:2003;4215-4220.
53. Hammerschmidt S., Talay S.R., Brandtzaeg P., Chhatwal G.S. SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol Microbiol. 25:1997;1113-1124.
54. Tong H.H., Blue L.E., James M.A., DeMaria T.F. Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase- deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect Immun. 68:2000;921-924.
55. McCullers J.A., Tuomanen E.I. Molecular pathogenesis of pneumococcal pneumonia. Front Biosci. 6:2001;D877-D889.
56. Weiser J.N., Markiewicz Z., Tuomanen E.I., Wani J.H. Relationship between phase variation in colony morphology, intrastrain variation in cell wall physiology, and nasopharyngeal colonization by Streptococcus pneumoniae. Infect Immun. 64:1996;2240-2245.
57. Weiser J.N., Kapoor M. Effect of intrastrain variation in the amount of capsular polysaccharide on genetic transformation of Streptococcus pneumoniae: implications for virulence studies of encapsulated strains. Infect Immun. 67:1999;3690-3692.
58. Kim J.O., Weiser J.N. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J Infect Dis. 177:1998;368-377.
59. Briles D.E., Hollingshead S., Brooks-Walter A., et al. The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection. Vaccine. 18:2000;1707-1711.
60. Muhlemann K., Matter H.C., Tauber M.G., Bodmer T. Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infection, Switzerland, 1998-1999. J Infect Dis. 187:2003;589-596.
61. Daw N.C., Wilimas J.A., Wang W.C., et al. Nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae in children with sickle cell disease. Pediatrics. 99:1997;E7.
62. Norris C.F., Mahannah S.R., Smith-Whitley K., Ohene-Frempong K., McGowan K.L. Pneumococcal colonization in children with sickle cell disease. J Pediatr. 129:1996;821-827.
63. Coles C.L., Kanungo R., Rahmathullah L., et al. Pneumococcal nasopharyngeal colonization in young South Indian infants. Pediatr Infect Dis J. 20:2001;289-295.
64. Syrogiannopoulos G.A., Grivea I.N., Davies T.A., Katopodis G.D., Appelbaum P.C., Beratis N.G. Antimicrobial use and colonization with erythromycin-resistant Streptococcus pneumoniae in Greece during the first 2 years of life. Clin Infect Dis. 31:2000;887-893.
65. Jebaraj R., Cherian T., Raghupathy P., et al. Nasopharyngeal colonization of infants in southern India with Streptococcus pneumoniae. Epidemiol Infect. 123:1999;383-388.
66. Syrjanen R.K., Kilpi T.M., Kaijalainen T.H., Herva E.E., Takala A.K. Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old. J Infect Dis. 184:2001;451-459.
67. Soewignjo S., Gessner B.D., Sutanto A., et al. Streptococcus pneumoniae nasopharyngeal carriage prevalence, serotype distribution, and resistance patterns among children on Lombok Island, Indonesia. Clin Infect Dis. 32:2001;1039-1043.
68. Rusen I.D., Fraser-Roberts L., Slaney L., et al. Nasopharyngeal pneumococcal colonization among Kenyan children: antibiotic resistance, strain types and associations with human immunodeficiency virus type 1 infection. Pediatr Infect Dis J. 16:1997;656-662.
69. Chiou C.C., Liu Y.C., Huang T.S., et al. Extremely high prevalence of nasopharyngeal carriage of penicillin- resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan. J Clin Microbiol. 36:1998;1933-1937.
70. Polack F.P., Flayhart D.C., Zahurak M.L., Dick J.D., Willoughby R.E. Colonization by Streptococcus penumoniae in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 19:2000;608-612.
71. Parry C.M., Diep T.S., Wain J., et al. Nasal carriage in Vietnamese children of Streptococcus pneumoniae resistant to multiple antimicrobial agents. Antimicrob Agents Chemother. 44:2000;484-488.
72. Vives M., Garcia M.E., Saenz P., et al. Nasopharyngeal colonization in Costa Rican children during the first year of life. Pediatr Infect Dis J. 16:1997;852-858.
73. Berkovitch M., Bulkowstein M., Zhovtis D., et al. Colonization rate of bacteria in the throat of healthy infants. Int J Pediatr Otorhinolaryngol. 63:2002;19-24.
74. Marchisio P., Claut L., Rognoni A., et al. Differences in nasopharyngeal bacterial flora in children with nonsevere recurrent acute otitis media and chronic otitis media with effusion: implications for management. Pediatr Infect Dis J. 22:2003;262-268.
75. Marchisio P., Esposito S., Schito G.C., Marchese A., Cavagna R., Principi N. Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children: implications for the use of heptavalent pneumococcal conjugate vaccine. Emerg Infect Dis. 8:2002;479-484.
76. Dejsirilert S., Overweg K., Sluijter M., et al. Nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children with acute respiratory tract infections in Thailand: a molecular epidemiological survey. J Clin Microbiol. 37:1999;1832-1838.
77. Dagan R., Leibovitz E., Greenberg D., Yagupsky P., Fliss D.M., Leiberman A. Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Pediatr Infect Dis J. 17:1998;880-885.
78. Veenhoven R., Bogaert D., Uiterwaal C., et al. Effect of pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media. Lancet. 361:2003;2189-2195.
79. Raymond J., Le Thomas I., Moulin F., Commeau A., Gendrel D., Berche P. Sequential colonization by Streptococcus pneumoniae of healthy children living in an orphanage. J Infect Dis. 181:2000;1983-1988.
80. Leibovitz E., Dragomir C., Sfartz S., et al. Nasopharyngeal carriage of multidrug-resistant Streptococcus pneumoniae in institutionalized HIV-infected and HIV-negative children in northeastern Romania. Int J Infect Dis. 3:1999;211-215.
81. Lee H.J., Park J.Y., Jang S.H., Kim J.H., Kim E.C., Choi K.W. High incidence of resistance to multiple antimicrobials in clinical isolates of Streptococcus pneumoniae from a university hospital in Korea. Clin Infect Dis. 20:1995;826-835.
82. Chiu S.S., Ho P.L., Chow F.K., Yuen K.Y., Lau Y.L. Nasopharyngeal carriage of antimicrobial-resistant Streptococcus pneumoniae among young children attending 79 kindergartens and day care centers in Hong Kong. Antimicrob Agents Chemother. 45:2001;2765-2770.
83. Petrosillo N., Pantosti A., Bordi E., et al. Prevalence, determinants, and molecular epidemiology of Streptococcus pneumoniae isolates colonizing the nasopharynx of healthy children in Rome. Eur J Clin Microbiol Infect Dis. 21:2002;181-188.
84. Fujimori I., Hisamatsu K., Kikushima K., Goto R., Murakami Y., Yamada T. The nasopharyngeal bacterial flora in children with otitis media with effusion. Eur Arch Otorhinolaryngol. 253:1996;260-263.
85. Dunais B., Pradier C., Carsenti H., et al. Influence of child care on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae. Pediatr Infect Dis J. 22:2003;589-592.
86. Yagupsky P., Porat N., Fraser D., et al. Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel. J Infect Dis. 177:1998;1003-1012.
87. Givon-Lavi N., Dagan R., Fraser D., Yagupsky P., Porat N. Marked differences in pneumococcal carriage and resistance patterns between day care centers located within a small area. Clin Infect Dis. 29:1999;1274-1280.
88. Sa-Leao R., Tomasz A., Sanches I.S., et al. Carriage of internationally spread clones of Streptococcus pneumoniae with unusual drug resistance patterns in children attending day care centers in Lisbon, Portugal. J Infect Dis. 182:2000;1153-1160.
89. Pelton S.I., Dagan R., Gaines B.M., et al. Pneumococcal conjugate vaccines: proceedings from an Interactive Symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Vaccine. 21:2003;1562-1571.
90. Davies T., Goering R.V., Lovgren M., Talbot J.A., Jacobs M.R., Appelbaum P.C. Molecular epidemiological survey of penicillin-resistant Streptococcus pneumoniae from Asia, Europe, and North America. Diagn Microbiol Infect Dis. 34:1999;7-12.
91. Sibold C., Wang J., Henrichsen J., Hakenbeck R. Genetic relationships of penicillin-susceptible and -resistant Streptococcus pneumoniae strains isolated on different continents. Infect Immun. 60:1992;4119-4126.
92. Overturf G.D. American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics. 106:2000;367-376.
93. Kroon F.P., van Dissel J.T., Ravensbergen E., Nibbering P.H., van Furth R. Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-year follow-up of antibody concentrations. Vaccine. 18:1999;524-530.
94. Yeh S.H., Zangwill K.M., Lee H., et al. Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants. Vaccine. 21:2003;2627-2631.
95. Mbelle N., Huebner R.E., Wasas A.D., Kimura A., Chang I., Klugman K.P. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis. 180:1999;1171-1776.
96. Dagan R., Givon-Lavi N., Zamir O., et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis. 185:2002;927-936.
97. Lloyd-Evans N., O'Dempsey T.J., Baldeh I., et al. Nasopharyngeal carriage of pneumococci in Gambian children and in their families. Pediatr Infect Dis J. 15:1996;866-871.
98. Brueggemann A.B., Griffiths D.T., Meats E., Peto T., Crook D.W., Spratt B.G. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis. 187:2003;1424-1432.
99. Hausdorff W.P., Bryant J., Paradiso P.R., Siber G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis. 30:2000;100-121.
100. Porat N., Trefler R., Dagan R. Persistence of two invasive Streptococcus pneumoniae clones of serotypes 1 and 5 in comparison to that of multiple clones of serotypes 6B and 23F among children in southern Israel. J Clin Microbiol. 39:2001;1827-1832.
101. Koskela M., Leinonen M., Haiva V.M., Timonen M., Makela P.H. First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants. Pediatr Infect Dis. 5:1986;45-50.
102. Leinonen M., Sakkinen A., Kalliokoski R., Luotonen J., Timonen M., Makela P.H. Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children. Pediatr Infect Dis. 5:1986;39-44.
103. O'Brien K.L., Steinhoff M.C., Edwards K., Keyserling H., Thoms M.L., Madore D. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide. vaccines. Pediatr Infect Dis J. 15:1996;425-430.
104. Peeters C.C., Tenbergen-Meekes A.M., Haagmans B., et al. Pneumococcal conjugate vaccines. Immunol Lett. 30:1991;267-274.
105. Black S., Shinefield H., Fireman B., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 19:2000;187-195.
106. Black S.B., Shinefield H.R., Ling S., et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J. 21:2002;810-815.
107. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep 2000; 49: 1-35.
108. Fireman B., Black S.B., Shinefield H.R., Lee J., Lewis E., Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J. 22:2003;10-16.
109. Eskola J., Kilpi T., Palmu A., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 344:2001;403-409.
110. Lakshman R., Murdoch C., Race G., Burkinshaw R., Shaw L., Finn A. Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy. Arch Dis Child. 88:2003;211-214.
111. Dagan R., Muallem M., Melamed R., Leroy O., Yagupsky P. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr Infect Dis J. 16:1997;1060-1064.
112. Dagan R., Melamed R., Muallem M., et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis. 174:1996;1271-1278.
113. Givon-Lavi N., Fraser D., Dagan R. Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings. Pediatr Infect Dis J. 22:2003;524-532.
114. Dagan R., Givon-Lavi N., Zamir O., Fraser D. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatr Infect Dis J. 22:2003;532-540.
115. Hausdorff W.P., Siber G., Paradiso P.R. Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet. 357:2001;950-952.
116. Hsu K, Pelton D, Heisey-Grove S, Hashemi J, Klein J, Health aMotMDoP. Conjugate vaccine era serotype-specific surveillance for invasive pneumococcal disease in massachusetts children: Program and abstracts of the 21st Annual Meeting of the European Society for Paediatric Infectious Diseases, Giardini Naxos, April 9-11, 2003.
117. Veenhoven R. Impact of combined pneumococcal conjugate and polysaccharide vaccination on nasopharyngeal carriage in children with recurrent acute otitis media. Program and abstracts of the 3rd International Symposium on Pneumococci and Pneumococcal Diseases; Anchorage; May 5-8, 2002.
118. Edwards K., Wandling G., Palmer P., Decker M. Carriage of pneumococci among infants immunized with a 9-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age. Clin Infect Dis. 29:1999;966.
119. O'Brien K, Bronsdon M, Carlone G, Facklam R, Schwartz B, Reid R. Effect of a 7-valent pneumococcal conjugate vaccine on nasopharyngeal carriage among navajo and white mountain apache infants. Proceedings of the 19th Annual Meeting of the European Society for Paediatric Infectious Diseases; Istanbul, Turkey; March 26-28, 2001.
120. Yother J., Handsome G.L., Briles D.E. Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene. J Bacteriol. 174:1992;610-618.
121. Yother J., Briles D.E. Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis. J Bacteriol. 174:1992;601-609.
122. Tu A.H., Fulgham R.L., McCrory M.A., Briles D.E., Szalai A.J. Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae. Infect Immun. 67:1999;4720-4804.
123. Neeleman C., Geelen S.P., Aerts P.C., et al. Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H. Infect Immun. 67:1999;4517-4524.
124. Wu H.Y., Nahm M.H., Guo Y., Russell M.W., Briles D.E. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J Infect Dis. 175:1997;839-846.
125. Ogunniyi A.D., Folland R.L., Briles D.E., Hollingshead S.K., Paton J.C. Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae. Infect Immun. 68:2000;3028-3033.
126. Briles D.E., King J.D., Gray M.A., McDaniel L.S., Swiatlo E., Benton K.A. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine. 14:1996;858-867.
127. Arulanandam B.P., Lynch J.M., Briles D.E., Hollingshead S., Metzger D.W. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection. Infect Immun. 69:2001;6718-672467.
128. Nabors G.S., Braun P.A., Herrmann D.J., et al. Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine. 18:2000;1743-1754.
129. Briles D.E., Hollingshead S.K., King J., et al. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J Infect Dis. 182:2000;1694-1701.
130. Dintilhac A., Alloing G., Granadel C., Claverys J.P. Competence and virulence of Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for Zn and Mn resulting from inactivation of putative ABC metal permeases. Mol Microbiol. 25:1997;727-739.
131. Briles D.E., Ades E., Paton J.C., et al. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect Immun. 68:2000;796-800.
132. Johnson S.E., Dykes J.K., Jue D.L., Sampson J.S., Carlone G.M., Ades E.W. Inhibition of pneumococcal carriage in mice by subcutaneous immunization with peptides from the common surface protein pneumococcal surface adhesin A. J Infect Dis. 185:2002;489-496.
133. Gor D.O., Ding X., Li Q., Schreiber J.R., Dubinsky M., Greenspan N.S. Enhanced immunogenicity of pneumococcal surface adhesin A by genetic fusion to cytokines and evaluation of protective immunity in mice. Infect Immun. 70:2002;5589-5595.
134. Romero-Steiner S., Pilishvili T., Sampson J.S., et al. Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies. Clin Diagn Lab Immunol. 10:2003;246-251.
135. Seo J.Y., Seong S.Y., Ahn B.Y., Kwon I.C., Chung H., Jeong S.Y. Cross-protective immunity of mice induced by oral immunization with pneumococcal surface adhesin a encapsulated in microspheres. Infect Immun. 70:2002;1143-1149.
136. Rapola S., Kilpi T., Lahdenkari M., Takala A.K., Makela P.H., Kayhty H. Do antibodies to pneumococcal surface adhesin a prevent pneumococcal involvement in acute otitis media? J Infect Dis. 184:2001;577-581.
137. Rapola S., Jantti V., Eerola M., Makela P.H., Kayhty H., Kilpi T. Anti-PsaA and the risk of pneumococcal AOM and carriage. Vaccine. 21:2003;3608-3613.
138. Hirst R.A., Sikand K.S., Rutman A., Mitchell T.J., Andrew P.W., O'Callaghan C. Relative roles of pneumolysin and hydrogen peroxide from Streptococcus pneumoniae in inhibition of ependymal ciliary beat frequency. Infect Immun. 68:2000;1557-1562.
139. Berry A.M., Yother J., Briles D.E., Hansman D., Paton J.C. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect Immun. 57:1989;2037-2042.
140. Kadioglu A., Taylor S., Iannelli F., Pozzi G., Mitchell T.J., Andrew P.W. Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type. Infect Immun. 70:2002;2886-2890.
141. Wellmer A., Zysk G., Gerber J., et al. Decreased virulence of a pneumolysin-deficient strain of Streptococcus pneumoniae in murine meningitis. Infect Immun. 70:2002;6504-6508.
142. Lock R.A., Paton J.C., Hansman D. Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniae. Microb Pathog. 5:1988;461-467.
143. Paton J.C., Lock R.A., Hansman D.J. Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae. Infect Immun. 40:1983;548-552.
144. Lynch J.M., Briles D.E., Metzger D.W. Increased protection against pneumococcal disease by mucosal administration of conjugate vaccine plus interleukin-12. Infect Immun. 71:2003;4780-4788.
145. Dagan R, Fraser D. Conjugate pneumococcal vaccine and antibiotic-resistant Streptococcus pneumoniae: herd immunity and reduction of otitis morbidity, Pediatr Infect Dis J 2000; 19 (suppl): S79-87; discussion S88.
146. Cakan G., Turkoz M., Turan T., Ahmed K., Nagatake T. S- carboxymethylcysteine inhibits the attachment of Streptococcus pneumoniae to human pharyngeal epithelial cells. Microb Pathog. 34:2003;261-265.
147. Adamou J.E., Heinrichs J.H., Erwin A.L., et al. Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect Immun. 69:2001;949-958.
148. Berry A.M., Lock R.A., Hansman D., Paton J.C. Contribution of autolysin to virulence of Streptococcus pneumoniae. Infect Immun. 57:1989;2324-2330.